SLDB · ISSUER CIK 1707502
Solid Biosciences Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Solid Biosciences Inc. insiders reported $0.00 of open-market purchases and $25K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$25KInsider selling
−$25KNet open-market
Oct 20, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 202616:05 | Oct 19, 2026 | SLDB | Chief Medical Officer | S · Sell10b5-1 | $5.62 | −4,374 | 97,241 | -4% | −$25K | ||
| Oct 20, 202616:05 | Oct 18, 2026 | SLDB | Chief Medical Officer | M · Exercise10b5-1 | — | +9,750 | 101,615 | +11% | — | ||
| Oct 6, 202616:35 | Oct 2, 2026 | SLDB | Director | M · Exercise | — | +3,440 | 141,585 | +2% | — |